Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375737 · ClinicalTrials.gov registry record · NA
Evaluating CVD Medication Adherence Program in Low SES
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02375737 is a NA study that has completed, run by Duke University. The registered enrollment target is 100 participants.
The verdict
NCT02375737, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The investigators propose to evaluate the implementation of an efficacious medication adherence program in a group at high risk for CVD. The program involves patients receiving/responding to e-reminders to take CVD medications via patient-selected technology \[mobile/web-based applications, short message service (SMS; text messaging), interactive voice response (IVR), or e-mail\] supported by a tailored, monthly, self-management program administered by either research staff or a case manager staff member from the Duke Outpatient Clinic via the telephone. This is a hybrid type II implementation science study.
Interventions
- BEHAVIORAL m-health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02375737
The ClinicalTrials.gov registry entry for NCT02375737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which m-health is the first listed.
NCT02375737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02375737 about?
NCT02375737 is a clinical study titled "Evaluating CVD Medication Adherence Program in Low SES". The investigators propose to evaluate the implementation of an efficacious medication adherence program in a group at high risk for CVD. The program involves patients receiving/responding to e-reminders to take CVD medications via patient-selected technology \[mobile/web-based applications, short me...
What is the current status of trial NCT02375737?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02375737?
The interventions under investigation include: m-health (BEHAVIORAL).
Who is sponsoring clinical trial NCT02375737?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.